糖分解性代謝物は,BRCA2による"二重ヒット"腫瘍抑制をバイパスする
Li Ren Kong1, Komal Gupta2, Andy Jialun Wu3
1Cancer Science Institute of Singapore, Singapore 117599, Singapore; NUS Centre for Cancer Research (N2CR), National University of Singapore, Singapore 117599, Singapore; MRC Cancer Unit, University of Cambridge, Cambridge CB2 0XZ, UK; Department of Pharmacology, National University of Singapore, Singapore 117600, Singapore.
Cell
|April 12, 2024
まとめ
メチルグリオキサル (MGO) は一時的にBRCA2を不活性化させ,2つのヒットがんモデルをバイパスします. この代謝メカニズムは,MGOと癌の発生における特定の変異シグネチャーを結びつける.
科学分野:
- 生物化学
- 遺伝学
- 腫瘍学
背景:
- Knudsonの"二重ヒット"パラダイムは,腫瘍抑制遺伝子の両方のコピーが不活性化されることが必要であると説明しています.
- BRCA2はDNA修復に関与する重要な乳がん抑制タンパク質です.
研究 の 目的:
- メチルグリオキサール (MGO) の癌発症における役割を"二重打撃"のパラダイムを超えて調査する.
- MGOによるBRCA2の一時的な無活性化とその変異シグネチャーとの関連を調べる.
主な方法:
- 非悪性乳腺細胞と患者からのオーガノイドの分析
- クラス駆動型のマウンの臓がんとヒトの乳がんにおけるMGO蓄積とDNA損傷の調査.
- BRCA2タンパク質分解と機能的ハプロイン不全の評価
主要な成果:
- MGOはBRCA2を一時的に不活性化させ,バイアレル不活性化なしに単基置換 (SBS) シグネチャーを引き起こします.
- ゲルムライン単型BRCA2変異は,MGO誘発SBSシグネチャーを誘発する.
- 断続的なMGO被曝は,永久的なBRCA2損失なしにエピソード的な変異をもたらす.
結論:
- MGO誘発のBRCA2ハプロイン欠乏症は,Knudsonの2回ヒット要求を回避する代謝メカニズムを提供します.
- この経路は,代謝不調 (例えば,糖分解の活性化) を癌に関連した変異シグネチャーと結びつける.
- 発見は,一時的な腫瘍抑制器の不活性化による代謝と癌の進化の間の新しい関連を示唆しています.
関連する概念動画
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


